SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001725160-24-000095
Filing Date
2024-04-29
Accepted
2024-04-29 16:31:43
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 ARS a2024ars.pdf ARS 16317948
  Complete submission text file 0001725160-24-000095.txt   22478354
Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39263 | Film No.: 24891522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)